查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040462

即時PCR、數位PCR和終點PCR市場規模、佔有率和趨勢分析報告：按技術、產品、應用、地區和細分市場分類（2026-2033年）

Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

即時PCR、數位PCR和終點PCR市場概述

2025年全球即時PCR、數位PCR和終點PCR市場價值為105.8億美元，預計2033年將達到213.1億美元，2026年至2033年的複合年成長率為9.2%。

市場成長的促進因素包括感染疾病和癌症的日益普及、對早期準確診斷的需求不斷成長以及精準醫療的日益普及。

多重PCR和高靈敏度數位PCR等技術進步進一步加速了其應用。美國疾病管制與預防中心（CDC）2025年12月的報告指出，美國每年約有1%的新生兒患有先天性心臟疾病，凸顯了產前基因檢測日益成長的需求。 PCR技術能夠早期發現基因突變，從而支持及時診斷和治療決策。

性行為感染（STI）如愛滋病毒（HIV）和人類乳突病毒（HPV）感染率的不斷上升，以及包括阿茲海默症、鏈球菌感染疾病、透納氏症和帕金森氏症在內的慢性疾病、感染疾病和遺傳性疾病病例的增加，顯著擴大了目標患者群體，從而推動了即時PCR、數位PCR和終點市場的成長。這些疾病需要高度敏感和精準的分子診斷工具來進行早期檢測和疾病監測。例如，根據世界衛生組織2025年7月發布的報告，全球約有130萬人將感染愛滋病毒，凸顯了感染疾病持續帶來的沉重負擔。此外，歐洲監測數據顯示，2024年新增愛滋病毒感染病例超過105,922例，多個國家呈現上升趨勢。疾病發生率的上升正在加速對基於PCR的診斷解決方案的需求。

數位PCR (dPCR) 在精準醫療領域的快速應用是推動市場成長的主要動力。與傳統PCR方法不同，dPCR無需標準曲線即可達到絕對定量，具有超高的靈敏度，並能更精確地檢測罕見基因突變。因此，dPCR在腫瘤學、感染疾病監測和基因檢測等領域尤其重要，因為在這些領域，精準檢測對於早期診斷和治療方法的選擇至關重要。此外，dPCR還具有更高的重複性和可靠性，支持其在臨床和研究領域的廣泛應用。例如，2025年7月，Bio-Rad公司推出了QX Continuum和QX700系統，擴展了其液滴數位PCR產品線，支援超過40萬種檢測。這項進展鞏固了dPCR在精準診斷中的地位，並加速了其在先進醫療應用中的普及。

多重技術和檢測方法的進步顯著提高了基於PCR的診斷效率和處理能力，從而推動了市場成長。先進的多重PCR系統能夠在一次檢測中同時檢測多種病原體，從而縮短檢測時間、降低營運成本並減少檢體需求。例如，FlashDx於2025年11月推出了一款基於半固體即時PCR即時PCR系統，實現了從樣本到檢體的無縫工作流程和快速多病原體檢測。此外，2026年1月發表的一項研究開發了一種多重RT- qPCR篩檢，能夠同時檢測18種呼吸道病毒，靈敏度高達99.81%，特異性達100%。這顯著提高了診斷處理能力，進一步提升了診斷準確性和檢查室效率。

此外，對可攜式、快速且易於使用的診斷系統的需求日益成長，以及即時檢測（POC​​）和分散式檢查的擴展，正顯著推動PCR市場的發展。小型化PCR設備能夠更快地獲得檢測結果，並便於在診所、機場和偏遠地區進行檢測，從而加強疫情防治和現場診斷能力。同時，對高通量、自動化系統的需求不斷成長，促使檢查室採用能夠以最少的人工干預處理大量檢體的先進平台。這減少了誤差，提高了效率。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：即時PCR、數位PCR和終點PCR市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 即時PCR、數位PCR和終點PCR的市場分析工具。
  • 法律規範
  • 救贖方案

第4章：即時PCR、數位PCR和終點PCR市場：按技術分類的估算和趨勢分析

  • 即時PCR、數位螢光定量PCR和終點螢光定量PCR市場：基於技術的波動分析
  • 即時PCR、數位PCR和終點PCR市場：基於技術的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 定量
    • 耗材和試劑
    • 裝置
    • 軟體服務
  • 數位的
    • 耗材和試劑
    • 裝置
    • 軟體服務
  • 終點PCR
    • 耗材和試劑
    • 裝置
    • 軟體服務

第5章：即時PCR(qPCR)、終點PCR和dPCR市場：分析、產品範圍、2021-2033年（收入）

  • 即時PCR(qPCR)、終點PCR和數位PCR市場：產品波動分析
  • 耗材和試劑
  • 裝置
  • 軟體服務

第6章：即時PCR(qPCR)、終點PCR和dPCR市場：分析、範圍、2021-2033年（收入）

  • 即時PCR(qPCR)、終點PCR和數位PCR市場：應用波動分析
  • 臨床階段
  • 研究
  • 法醫學及其他

第7章即時PCR(qPCR)、終點PCR和dPCR市場：分析、區域範圍、2021-2033年（收入）

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
  • 主要銷售代理商和通路夥伴名單
  • Key customers
  • 主要公司市佔率分析（2025 年）
  • 公司簡介
    • Abbott
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • GE Healthcare
    • BioMerieux SA
    • F. Hoffmann-La Roche Ltd
    • Fluidigm Corporation
Product Code: GVR-1-68038-552-6

Real-time PCR, Digital PCR, And End-point PCR Market Summary

The global real-time PCR, digital PCR, and end-point PCR market size was valued at USD 10.58 billion in 2025 and is expected to reach USD 21.31 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. Market growth is driven by the rising prevalence of infectious diseases and cancer, increasing demand for early and accurate diagnostics, and the growing adoption of precision medicine.

Technological advancements such as multiplex PCR, digital PCR for high sensitivity, are further accelerating adoption. According to a CDC report December 2025, congenital heart defects affect approximately 1% of births annually in the U.S., highlighting the growing need for prenatal genetic testing. PCR technologies enable early detection of genetic variations, supporting timely diagnosis and treatment decisions.

The growing incidence of sexually transmitted infections (STIs) such as HIV and HPV, along with rising cases of chronic, infectious, and genetic disorders, including Alzheimer's disease, Streptococcal infections, Turner syndrome, and Parkinson's disease, is significantly expanding the target patient population, thereby driving the growth of real-time PCR, digital PCR, and end-point PCR markets. These conditions require highly sensitive and accurate molecular diagnostic tools for early detection and disease monitoring. For instance, according to a WHO report in July 2025, approximately 1.3 million people globally acquired HIV, highlighting the continued burden of infectious diseases. In addition, European surveillance data reported over 105,922 HIV diagnoses in 2024, with several countries observing increasing trends. Such rising disease incidence is accelerating the demand for PCR-based diagnostic solutions.

The rapid adoption of digital PCR (dPCR) for precision medicine is a key driver of market growth. Unlike conventional PCR methods, dPCR enables absolute quantification without the need for standard curves, offering ultra-high sensitivity and the ability to detect rare genetic mutations with greater accuracy. This makes it particularly valuable in oncology, infectious disease monitoring, and genetic testing, where precise detection is critical for early diagnosis and treatment selection. In addition, dPCR provides improved reproducibility and reliability, supporting its increasing use in clinical and research settings. For instance, in July 2025, Bio-Rad expanded its Droplet Digital PCR portfolio with the launch of the QX Continuum and QX700 systems, which support over 400,000 assays. This advancement reinforces dPCR's role in precision diagnostics and accelerates its adoption across advanced healthcare applications.

Technological advancements in multiplexing and assay innovation are significantly improving the efficiency and throughput of PCR-based diagnostics, thereby driving market growth. Advanced multiplex PCR systems enable the simultaneous detection of multiple pathogens in a single test, reducing turnaround time, operational costs, and sample requirements. For instance, in November 2025, FlashDx introduced a fully automated multiplex real-time PCR system based on semi-solid phase real-time PCR (sSPRT) technology, enabling a seamless sample-to-result workflow and rapid multi-pathogen detection. In addition, a study published in January 2026 developed a multiplex RT-qPCR assay capable of detecting 18 respiratory viruses simultaneously, demonstrating high sensitivity up to 99.81% and specificity 100%, significantly improving diagnostic throughput, further enhancing diagnostic accuracy, and laboratory productivity.

Moreover, the growth of point-of-care (POC) and decentralized testing is significantly driving the PCR market, supported by increasing demand for portable, rapid, and easy-to-use diagnostic systems. Miniaturized PCR devices enable faster turnaround times and facilitate testing in clinics, airports, and remote settings, strengthening pandemic preparedness and on-site diagnostics. Simultaneously, the rising demand for high-throughput, automated systems is encouraging laboratories to adopt advanced platforms that process large sample volumes with minimal human intervention, thereby reducing errors and improving efficiency.

Global Real-time PCR, Digital PCR, And End-point PCR Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global real time PCR, digital PCR, and end-point PCR market report on the basis of technology, application, product, and regions.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Quantitative
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • Digital
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • End-point
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables & Reagents
  • Instruments
  • Software & Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical
    • Pathogen Testing
    • Oncology testing
    • Blood Screening
    • Liquid Biopsy
    • dPCR-based Non-Invasive Prenatal Testing (NIPT)
    • Others
  • Research
    • Stem Cell Research
    • DNA Cloning & Sequencing
    • Recombinant DNA Technology
    • Rare Mutation Detection
    • Gene Expression
    • Single Cell Analysis
    • Microbiome Analysis
    • Copy Number Variation Analysis
    • Library Quantification (NGS)
    • Characterization of Low-fold Changes in mRNA and miRNA Expression.
    • Species Identification
    • GMO Detection
    • Others
  • Forensic
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
    • 1.2.3. Application
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Objectives
    • 1.3.1. Objective-1
    • 1.3.2. Objective-2
    • 1.3.3. Objective-3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased database
    • 1.5.2. GVR's internal database
    • 1.5.3. Secondary sources
    • 1.5.4. Primary research
  • 1.6. Information or Data Analysis
    • 1.6.1. Data analysis models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity flow analysis
      • 1.8.1.1. Approach 1: Commodity flow approach
      • 1.8.1.2. Approach 2: Country-wise market estimation using bottom-up approach
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Technology Snapshot
  • 2.3. Product Snapshot
  • 2.4. Application Snapshot
  • 2.5. Competitive Insights

Chapter 3. Real Time PCR, Digital PCR and End-Point PCR Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook (Drug Testing Market)
    • 3.1.2. Related/ancillary market outlook (Drug Screening Market)
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of infectious diseases and cancer
      • 3.2.1.2. Increasing demand for early and accurate diagnostics
      • 3.2.1.3. Growing adoption of precision medicine.
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High device costs associated with Real time PCR (qPCR)
      • 3.2.2.2. Stringent regulatory policies
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of point-of-care (POC) and decentralized PCR testing
      • 3.2.3.2. Rising adoption of digital PCR in precision medicine
      • 3.2.3.3. Advancements in multiplexing and AI-integrated PCR platforms
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. High cost of advanced PCR instruments and reagents
      • 3.2.4.2. Stringent regulatory requirements and approval delays
      • 3.2.4.3. Shortage of skilled professionals and technical expertise
  • 3.3. Real Time PCR, Digital PCR and End-Point PCR Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Regulatory Framework
  • 3.5. Reimbursement Scenario

Chapter 4. Real Time PCR, Digital PCR and End-Point PCR Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Real Time PCR, Digital PCR and End-Point PCR Market: Technology Movement Analysis
  • 4.3. Real Time PCR, Digital PCR and End-Point PCR Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Quantitative
    • 4.5.1. Quantitative Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Consumables & reagents
      • 4.5.2.1. Consumables & reagents Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Instruments
      • 4.5.3.1. Instruments market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.5.4. Software & Services
    • 4.5.5. Software & Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Digital
    • 4.6.1. Digital market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.6.2. Consumables & Reagents
      • 4.6.2.1. Consumables & reagents market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.6.3. Instruments
      • 4.6.3.1. Instruments market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.6.4. Software & Services
      • 4.6.4.1. Software & services market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.7. End-point PCR
    • 4.7.1. End-point PCR market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.7.2. Consumables & Reagents
      • 4.7.2.1. Consumables & reagents market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.7.3. Instruments
      • 4.7.3.1. Instruments market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.7.4. Software & Services
      • 4.7.4.1. Software & services market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2021 - 2033 (Revenue, USD Million)

  • 5.1. Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
  • 5.2. Consumables & Reagents
    • 5.2.1. Consumables & Reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.3. Instruments
    • 5.3.1. Instruments market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.4. Software & Services
    • 5.4.1. Software & Services market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2021 - 2033 (Revenue, USD Million)

  • 6.1. Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis
  • 6.2. Clinical
    • 6.2.1. Clinical market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.2. Pathogen Testing
      • 6.2.2.1. Pathogen Testing market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.3. Oncology Testing
      • 6.2.3.1. Oncology Testing market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.4. Blood Screening
      • 6.2.4.1. Blood Screening market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.5. Liquid Biopsy Testing
      • 6.2.5.1. Liquid Biopsy Testing market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.6. dPCR-based Non-Invasive Prenatal Testing (NIPT)
      • 6.2.6.1. dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.2.7. Others
      • 6.2.7.1. 1 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3. Research
    • 6.3.1. Research market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.2. Stem Cell Research
      • 6.3.2.1. Stem cell research market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.3. DNA Cloning & Sequencing
      • 6.3.3.1. 1 DNA cloning & sequencing market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.4. Recombinant DNA Technology
      • 6.3.4.1. Recombinant DNA technology market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.5. Rare Mutation Detection
      • 6.3.5.1. Rare mutation detection market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.6. Gene Expression
      • 6.3.6.1. Gene expression market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.7. Single-Cell Analysis
      • 6.3.7.1. Single-Cell analysis market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.8. Microbiome Analysis
      • 6.3.8.1. Microbiome analysis market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.9. Copy Number Variation Analysis
      • 6.3.9.1. Copy number variation analysis market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.10. Library Quantification (NGS)
      • 6.3.10.1. Library Quantification (NGS) market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.11. Characterization of Low-fold Changes in mRNA and miRNA Expression
      • 6.3.11.1. Characterization of low-fold changes in mRNA and miRNA Expression market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.12. Species Identification
      • 6.3.12.1. Species identification market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.13. GMO Detection
      • 6.3.13.1. GMO detection market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.4. Forensics and Others
      • 6.4.1.1. Forensics and others market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2021 - 2033 (Revenue, USD Million)

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
  • 8.4. List of key distributors and channel partners
  • 8.5. Key customers
  • 8.6. Key company market share analysis, 2025
  • 8.7. Company Profiles
    • 8.7.1. Abbott
      • 8.7.1.1. Company overview
      • 8.7.1.2. Financial performance
      • 8.7.1.3. Product benchmarking
      • 8.7.1.4. Strategic initiatives
    • 8.7.2. QIAGEN
      • 8.7.2.1. Company overview
      • 8.7.2.2. Financial performance
      • 8.7.2.3. Product benchmarking
      • 8.7.2.4. Strategic initiatives
    • 8.7.3. Bio-Rad Laboratories, Inc.
      • 8.7.3.1. Company overview
      • 8.7.3.2. Financial performance
      • 8.7.3.3. Product benchmarking
      • 8.7.3.4. Strategic initiatives
    • 8.7.4. Agilent Technologies, Inc.
      • 8.7.4.1. Company overview
      • 8.7.4.2. Financial performance
      • 8.7.4.3. Product benchmarking
      • 8.7.4.4. Strategic initiatives
    • 8.7.5. Thermo Fisher Scientific, Inc.
      • 8.7.5.1. Company overview
      • 8.7.5.2. Financial performance
      • 8.7.5.3. Product benchmarking
      • 8.7.5.4. Strategic initiatives
    • 8.7.6. GE Healthcare
      • 8.7.6.1. Company overview
      • 8.7.6.2. Financial performance
      • 8.7.6.3. Product benchmarking
      • 8.7.6.4. Strategic initiatives
    • 8.7.7. BioMerieux SA
      • 8.7.7.1. Company overview
      • 8.7.7.2. Financial performance
      • 8.7.7.3. Product benchmarking
      • 8.7.7.4. Strategic initiatives
    • 8.7.8. F. Hoffmann-La Roche Ltd
      • 8.7.8.1. Company overview
      • 8.7.8.2. Financial performance
      • 8.7.8.3. Product benchmarking
      • 8.7.8.4. Strategic initiatives
    • 8.7.9. Fluidigm Corporation
      • 8.7.9.1. Company overview
      • 8.7.9.2. Financial performance
      • 8.7.9.3. Product benchmarking
      • 8.7.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Real time PCR, Digital PCR and End-Point PCR Market, By Region, 2021 - 2033 (USD Million)
  • Table 5 Global Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 7 Global Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 8 North America Real time PCR, Digital PCR and End-Point PCR Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 North America Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 North America Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 15 Canada Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 Canada Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 Canada Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million
  • Table 19 Europe Real time PCR, Digital PCR and End-Point PCR Market, By Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 21 Europe Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Europe Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 UK Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 UK Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 UK Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Germany Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 27 Germany Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 Germany Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 France Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 30 France Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 France Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 Italy Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 Italy Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 34 Italy Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Spain Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Spain Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Spain Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Denmark Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 39 Denmark Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 Denmark Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Norway Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 42 Norway Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Norway Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Sweden Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Sweden Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 46 Sweden Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Real time PCR, Digital PCR and End-Point PCR Market, By Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Japan Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Japan Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 Japan Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 China Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 55 China Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 56 China Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 India Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 58 India Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 India Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 South Korea Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 South Korea Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 South Korea Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 Australia Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 64 Australia Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 65 Australia Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 67 Thailand Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Thailand Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Latin America Real time PCR, Digital PCR and End-Point PCR Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 71 Latin America Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Latin America Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Brazil Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 Brazil Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 Brazil Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Argentina Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 Argentina Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 78 Argentina Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Middle East and Africa Real time PCR, Digital PCR and End-Point PCR Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 Middle East and Africa Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 81 Middle East and Africa Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 82 Middle East and Africa Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 83 South Africa Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 84 South Africa Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 85 South Africa Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 89 UAE Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 UAE Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 91 UAE Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Real time PCR, Digital PCR and End-Point PCR Market, By Technology, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Real time PCR, Digital PCR and End-Point PCR Market, By Product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Real time PCR, Digital PCR and End-Point PCR Market, By Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Real-time PCR (qPCR), end point PCR, and dPCR market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Real-time PCR (qPCR), end point PCR, and dPCR market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Real-time PCR (qPCR), end point PCR, and dPCR market driver impact
  • Fig. 14 Real-time PCR (qPCR), end point PCR, and dPCR market restraint impact
  • Fig. 15 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Ansoff Matrix
  • Fig. 19 Competitive dashboard analysis
  • Fig. 20 Regional network map
  • Fig. 21 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology outlook and key takeaways
  • Fig. 22 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology movement analysis& market share 2025 & 2030
  • Fig. 23 Quantitative market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Digital market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 End-point PCR market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Real-time PCR (qPCR), end point PCR, and dPCR market: Products outlook and key takeaways
  • Fig. 27 Real-time PCR (qPCR), end point PCR, and dPCR market: Products movement analysis & market share 2025 & 2030
  • Fig. 28 Consumables & reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Software & services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Real-time PCR (qPCR), end point PCR, and dPCR market: Application outlook and key takeaways
  • Fig. 32 Real-time PCR (qPCR), end point PCR, and dPCR market: Application movement analysis & market share 2025 & 2030
  • Fig. 33 Clinical market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Pathogen testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Oncology testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Blood screening market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Liquid Biopsy testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Research market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Stem cell research market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 DNA cloning & sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Recombinant DNA technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Rare mutation detection market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Gene expression market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Single-cell analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Microbiome analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Copy number variation analysis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Library quantification (NGS) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Characterization of low-fold changes in mRNA and miRNA expression market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Species identification market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 GMO detection market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Forensics and others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Real-time PCR (qPCR), end point PCR, and dPCR market: Regional outlook and key takeaways
  • Fig. 55 Regional outlook, 2025 & 2030
  • Fig. 56 North America. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Europe market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 UK market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 France market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Asia-Pacific market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 71 India. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 China market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 MEA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 81 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)